Osteoclast differentiation and activation
Top Cited Papers
- 1 May 2003
- journal article
- review article
- Published by Springer Nature in Nature
- Vol. 423 (6937), 337-342
- https://doi.org/10.1038/nature01658
Abstract
Osteoclasts are specialized cells derived from the monocyte/macrophage haematopoietic lineage that develop and adhere to bone matrix, then secrete acid and lytic enzymes that degrade it in a specialized, extracellular compartment. Discovery of the RANK signalling pathway in the osteoclast has provided insight into the mechanisms of osteoclastogenesis and activation of bone resorption, and how hormonal signals impact bone structure and mass. Further study of this pathway is providing the molecular basis for developing therapeutics to treat osteoporosis and other diseases of bone loss.Keywords
This publication has 77 references indexed in Scilit:
- Transgenic mice overexpressing soluble osteoclast differentiation factor (sODF) exhibit severe osteoporosisJournal of Bone and Mineral Metabolism, 2002
- Polymorphisms in the Osteoprotegerin Gene Are Associated With Osteoporotic FracturesJournal of Bone and Mineral Research, 2002
- Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expressionExperimental & Molecular Medicine, 2002
- NF-κB in cancer: from innocent bystander to major culpritNature Reviews Cancer, 2002
- RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-βNature, 2002
- Microphthalmia Transcription Factor Is a Target of the p38 MAPK Pathway in Response to Receptor Activator of NF-κB Ligand SignalingJournal of Biological Chemistry, 2002
- Receptor Activator of NF-κB Ligand (RANKL) Activates TAK1 Mitogen-Activated Protein Kinase Kinase Kinase through a Signaling Complex Containing RANK, TAB2, and TRAF6Molecular and Cellular Biology, 2002
- RANK Is the Essential Signaling Receptor for Osteoclast Differentiation Factor in OsteoclastogenesisBiochemical and Biophysical Research Communications, 1998
- Characterization of the Intracellular Domain of Receptor Activator of NF-κB (RANK)Journal of Biological Chemistry, 1998
- Requirement for NF-κB in osteoclast and B-cell developmentGenes & Development, 1997